Outbreak of measles in medical students and determination of immune status to measles-mumps-rubella viruses

International Journal of Adolescent Medicine and Health

Volumn 18, Issue 4, 2006, Pages 615-622

  Yalçin, Songül S ^a,b   Kanra, Güler ^a,b   Pehlivan, Tamer ^a,b  

^a HACETTEPE UNIVERSITY   (Turkey)

^b Aventis Pasteur   (Turkey)

Author keywords

History; Immunogenicity; Measles mumps rubella vaccine; Outbreak; Safety; Seroprevalence; Turkey

Indexed keywords

MEASLES MUMPS RUBELLA VACCINE;

ACUTE GASTROENTERITIS; ADULT; ANOREXIA; ARTHRALGIA; ARTICLE; BLOOD SAMPLING; CORRELATION ANALYSIS; DRUG EFFICACY; DRUG ERUPTION; DRUG FEVER; DRUG SAFETY; EPIDEMIC; ERYTHEMA; FEMALE; HUMAN; HUMAN EXPERIMENT; IMMUNOGENICITY; INJECTION PAIN; LYMPHADENOPATHY; MALE; MEASLES; MEASLES VIRUS; MEDICAL STUDENT; MUMPS VIRUS; MYALGIA; NORMAL HUMAN; PAROTITIS; RUBELLA VIRUS; SALIVARY GLAND DISEASE; SEROCONVERSION; SIDE EFFECT; SWELLING; TURKEY (REPUBLIC); UPPER RESPIRATORY TRACT INFECTION;

EID: 33847139049     PISSN: 03340139     EISSN: None     Source Type: Journal    
DOI: 10.1515/IJAMH.2006.18.4.615     Document Type: Article

References (21)

1. CDC. Measles, mumps, and rubella-vaccine use and strategies for elimination of measles, rubella, and congenital rubella syndrome and control of mumps: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Morb Mortal Wkly Rep 1998;47(RR-8):1-57.
2. Murray DL, Lynch MA. Determination of immune status to measles, rubella, and varicella-zoster viruses among medical students: assessment of historical information. Am J Public Health 1988;78:836-838.
3. Murray DL, Weatherly MR, Sperling JL, Farquhar LJ. Identification and immunization of medical students susceptible to measles and rubella: a national wide survey. Am J Public Health 1985;75:556-557.
4. Nichol KL, Olson R. Medical students' exposure and immunity to vaccine-preventable diseases. Arch Intern Med 1993;153:1913-1916
5. Poland GA, Nichol KL. Medical students as sources of rubella and measles outbreaks. Arch Intern Med 1990;150:44-46.
6. Pancharoen C, Wachirarojpaisan S, Pattamadilok S, Likitnukul S, Thisyakorn U. Measles in Thai adults: three case reports and management of contact cases. Southeast Asian J. Trop Med Public Health 2001;32:805-808.
7. de Quadros CA, Olive JM, Hersh BS, Strassburg MA, Henderson DA, Brandling-Bennett D, Alleyne GA. Measles elimination in the Americas Evolving strategies JAMA 1996;275: 224-229.
8. Hurley SB, Cummings SR. Designing Clinical Research. Williams and Wilkins, 1988.
9. Baer G, Bonhoeffer J, Schaad UB, Heininger U. Seroprevalence and immunization history of selected vaccine preventable diseases in medical students. Vaccine. 2005;23:2016-20.
10. Edmunds WJ, Gay NJ, Kretzschmar M, Pebody RG, Wachmannum H. The prevaccination epidemiology of measles, mumps and rubella in Europe: Implications for modelling studies. Epidemiol Infect 2000; 125: 635-650.
11. Kukino J, Naito T, Mitsuhashi K, Oshima H, Sekiya S, Isonuma H, et al. Susceptibility of medical students to vaccine-preventable viral diseases: a serological study. J Infect Chemother. 2004;10:335-7.
12. Nassar NT, Habbal A. Seroimmunity to measles and mumps among medical students and nurses in a teaching hospital in Lebanon. J Am Coll Health 1993;42:41-42.
13. Anderson RM, May RM. Directly transmitted infectious diseases: control by vaccination. Science 1982;215: 1053-1060.
14. Fine PE. Herd immunity: history, theory, practice. Epidemiol Rev 1993;15:265-302.
15. Kanra G, Yali̧n SS, Kara A, Yurdakök K. Pehlivanl T. Varicella seroprevalence among Turkish medical students and the validity of disease history. Infect Control Hosp Epidemiol 2003;24:795-6.
16. Tingle AJ, Mitchell LA, Grace M, Middleton P, Mathias R, MacWilliam L, Chalmers A. Randomised double-blind placebo-controlled study on adverse effects of rubella immunisation in seronagative women. Lancet, 1997;349:1277-1281.
17. Galazka AM, Robertson SE, Kraigher A. Mumps and mumps vaccine: a global review. Bull World Health Organ 1999;77:3-14.
18. CDC. Control and prevention of rubella: evaluation and management of suspected outbreaks, rubella in pregnant woman, and surveillance for congenital rubella syndrome. MMWR Morb Mortal Wkly Rep 2001;50 (RR-12):1-23.
19. CDC. Immunization of health-care workers: recommendations of the Advisory Committee on Immunization Practices (ACIP) and the Hospital Infection Control Practices Advisory Committee (HICPAC). MMWR Morb Mortal Wkly Rep 1997;46:(RR-18).
20. Poland GA, Nichol KL. Medical schools and immunization policies: missed opportunities for disease prevention. Ann Intern Med 1990;113: 628-631.
21. Rowan MS, Carter AO, Walker VJ. Immunization policies in Canadian medical schools. CMAJ. 1994;151, 957-961.